DBV Technologies - Aktienkurs

Aktienkurs
9.86
Täglich Wechseln
0.70 7.64%
Monatlich
27.39%
Jährlich
155.47%
Q3 Prognose
8.88

Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 21.41 -0.16 -0.74% 35.16% 2025-07-01
Alnylam Pharmaceuticals 323.47 -2.62 -0.80% 30.64% 2025-07-01
Amarin 16.59 0.37 2.28% 17.66% 2025-07-01
BioMarin Pharmaceutical 55.61 0.64 1.16% -32.36% 2025-07-01
DBV Technologies 9.86 0.70 7.64% 155.47% 2025-07-01
Halozyme Therapeutics 53.12 1.10 2.11% 3.55% 2025-07-01
Incyte 68.86 0.76 1.12% 16.63% 2025-07-01
Insmed 97.45 -3.19 -3.17% 51.09% 2025-07-01
Ionis Pharmaceuticals 39.76 0.25 0.63% -11.92% 2025-07-01
Neurocrine Biosciences 128.00 2.31 1.84% -6.90% 2025-07-01
PTC Therapeutics 48.42 -0.42 -0.86% 59.33% 2025-07-01
Ultragenyx Pharmaceutical 36.35 -0.01 -0.03% -11.25% 2025-07-01
Sarepta Therapeutics 17.65 0.55 3.19% -88.56% 2025-07-01
United Therapeutics 290.91 3.56 1.24% -8.24% 2025-07-01

Preis Tag Jahr Datum
USND 20203 -166.84 -0.82% 12.06% 2025-07-01